CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2016
Total Assets: $199.1M
Liabilities Breakdown FY2016
Total Liabilities: $120.6M
Asset Breakdown
Total Assets: $199.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $104.6M | 52.6% |
| Accounts Receivable | $2.2M | 1.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.4M | 2.2% |
| Goodwill | $949.0K | 0.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $87.0M | 43.7% |
Liabilities Breakdown
Total Liabilities: $120.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.6M | 5.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $114.1M | 94.5% |